Goldman Sachs India Equity ETF (GIND)

The Goldman Sachs India Equity ETF (ticker GIND) is a straightforward equity fund holding India’s largest and most-liquid public companies. No complexity. No leverage. No hedging. You own a slice of roughly 40 to 60 Indian firms — IT services, banks, pharmaceuticals, energy — and you share in their fortunes and risks.

The holdings and their story

GIND’s portfolio is dominated by three industry buckets: information technology and software services (the largest slice), financial services (banks, insurance, asset managers), and pharmaceuticals. IT services is outsized because firms like Tata Consultancy Services and Infosys are India’s largest multinational corporations, with global customer bases and high profit margins. The concentration is real. The top five holdings often represent 25 to 40% of the fund’s value. A single disappointing earnings report from one of these giants can move the fund meaningfully.

Pharmaceuticals feature because India has become a global supplier of generic drugs and active pharmaceutical ingredients — essentially, cost advantages translate into scale. Financial services are large because India’s banking sector is growing rapidly as credit penetrates deeper into the population. Energy and utilities show up because infrastructure development is steady. No single industry dominates in the way that IT does, but the concentration in IT services is the defining feature of this fund.

The India growth case

India has two characteristics that distinguish it from most developed markets. First, it still has a young, growing population and a rapidly expanding workforce — different from the aging, slow-growth developed world. Second, its economy is still undergoing the shift from subsistence agriculture to manufacturing and services, which creates tailwinds for companies riding that wave. Indian GDP has grown at six to eight percent annually for much of the past two decades, faster than most other large economies, and the demographic backdrop suggests that growth can persist for years.

GIND’s appeal to investors is precisely that case: a concentrated exposure to a rapidly growing, still-developing economy where corporate earnings can expand faster than in mature markets. The downside is that concentration also means faster declines if the growth story stalls. India’s inflation cycles, monetary policy shifts, and political changes affect the market differently than US factors do.

Currency is not optional

GIND trades in US dollars on a US exchange, but its holdings are priced in Indian rupees. When the dollar weakens, you benefit — your rupee-denominated holdings become more valuable in dollar terms. When the dollar strengthens, the fund loses value just from currency movement, regardless of what the underlying companies do. Over a year or two, currency swings can dwarf company-level returns. Over longer periods, currency and equity returns both matter. A US investor who bought GIND a decade ago when the rupee was strong and the dollar weak experienced very different returns than one who bought when the dynamic reversed. No hedge is in place — GIND passes currency risk directly to the investor.

Liquidity, accessibility, and costs

GIND itself trades with decent daily volume on US exchanges, but the underlying Indian stock market is less liquid and less transparent than US or European exchanges. Large institutional flows can move prices. Settlement times are longer. The expense ratio reflects these frictions — 0.75% annually is reasonable for a single-country emerging-markets fund but double the cost of a US index fund. Investors who view GIND as part of a broader diversified portfolio and who can tolerate larger daily swings than a US fund might experience should accept this cost structure.

India’s regulatory environment is also less stable than developed markets. A sudden capital-control tightening, a new tax on foreign investors, or a broader tightening of monetary policy can move the entire market. Political transitions and inflation cycles have outsized effect relative to what investors in developed markets expect. Single-country bets carry this idiosyncratic political and regulatory risk.

Field observations

Top holdings cluster around the multinational IT and pharma firms — companies with global reach and hard-to-replicate client bases. A material chunk of earnings comes from dollar revenues, which hedges the fund’s investors against pure rupee weakness (if the rupee falls and your IT company earns in dollars, the translation effect is positive). Banks are represented across the range of sizes, from large established players to smaller regional lenders riding rural credit expansion. Energy is present but not dominant — a reflection that India still imports much of its oil.

Turnover is low because GIND passively tracks an index, but the index itself reconstitutes periodically as companies’ market values shift and new firms qualify. Tax drag in a taxable account should be minimal.

Before committing capital

Read the prospectus. Understand the exact index GIND tracks and which companies make up the top positions. Pull the fund’s performance over five and ten years and compare it to broader emerging-markets ETFs and to India-specific equity comparisons. Ask yourself: am I betting on India’s growth story, or am I seeking diversification away from developed markets? If it is the former, GIND’s concentration is a feature. If it is the latter, a more diversified emerging-markets fund might suit you better. Watch the rupee’s long-term trend — a steadily weakening rupee is a headwind on dollar returns, even if Indian companies perform well. And be prepared for volatility. Emerging-markets growth comes with larger swings than US equity investors typically experience.